Active clinical trials for "Myopia"

This study is intended to show that the investigational contact lens is clinically equivalent to a currently approved contact lens, when worn as single-use on a daily basis.

This study is to investigate whether novel soft contact lens optical designs can slow myopia progression.

The objective of this study is to evaluate the clinical performance of two daily disposable contact lenses.

To evaluate the clinical results of anti-VEGF intra-vitreal injections (IVT) in CNV secondary to pathologic myopia (PM-CNV).

The purpose of this study is to compare subjective responses to two contact lenses after 15 minutes of wear.

The purpose of this trial is to assess the performance of a Lotrafilcon A contact lens over a 3-month period.

This study compares the performance of an investigational contact lens to a currently marketed lens.

The objective of the study is to compare clinical outcomes from PRK and SBK using FDA-approved laser technology in the same patient

In order we had designed a prospective clinical trial. Spherical equivalent refractive error (SER), axial length (AL), mean keratometric value (Mean-K), anterior chamber depth (ACD), and intraocular pressure (IOP) were measured at baseline and one week after topical use of 0.125% atropine. Postcycloplegic changes of refractive error and ocular parameters were evaluated, and their correlations were analyzed with multiple linear regression models.

This study is to evaluate the fitting performance of stenfilcon A contact lens (test) compared to narafilcon A contact lens (control).